The True Costs of the 21-Gene Assay in a Cohort of 1,000 Patients
Journal of Clinical Oncology (JCO) Podcast · Jennifer J. Griggs
December 1, 20176m 41s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This podcast addresses the clinical implications of the high cost of the 21-gene assay in women with ER-positive, node-negative breast cancer.
Related Article: Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay